A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy

BACKGROUND: Prostate cancer (PCa) is the second leading cause of cancer deaths in men in the United States. The prostate-specific antigen (PSA), often found at high levels in the serum of PCa patients, has been used as a marker for PCa detection and as a target of immunotherapy. The murine IgG1 mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniels-Wells, Tracy R, Helguera, Gustavo, Leuchter, Richard K, Quintero, Rafaela, Kozman, Maggie, Rodríguez, José A, Ortiz-Sánchez, Elizabeth, Martínez-Maza, Otoniel, Schultes, Birgit C, Nicodemus, Christopher F, Penichet, Manuel L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651304/
https://www.ncbi.nlm.nih.gov/pubmed/23594731
http://dx.doi.org/10.1186/1471-2407-13-195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651304/
https://www.ncbi.nlm.nih.gov/pubmed/23594731
http://dx.doi.org/10.1186/1471-2407-13-195

Ejemplares similares